CTLA4 and neoplasm: Using an established CT-26 tumor model, AlloDCs and anti-CTLA-4 Abs combined treatment significantly enhanced the effectiveness, with 70% of mice being cured and enhanced infiltration of activated antigen-presenting endogenous DCs and CD8+ T cells with a tissue-resident memory phenotype (CD49a+CD103+) observed [62].